Drug-delivery Funding

Bigfoot Biomedical lands $45M as it readies first diabetes product

Released on January 15, 2020

Bigfoot Biomedical Inc. has picked up some ammunition as it moves closer to commercializing its insulin-management solution, an up-and-coming competitor in […]

Read more
Drug-delivery Funding

Abbott Kicks in for Bigfoot’s $45M Financing

Released on January 13, 2020

It may only be January, but it looks like 2020 could be Bigfoot Biomedical’s year. The company is on track to […]

Read more
Drug-delivery Vascular

TriSalus launches TriNac Infusion System

Released on January 13, 2020

TriSalus this week launched its TriNac Infusion System. The infusion system is powered by the company’s Pressure-Enabled Drug Delivery (PEDD) approach with […]

Read more
Drug-delivery FDA

7 medtech advances to improve diabetes treatment

Released on January 10, 2020

Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple […]

Read more
Cardiology Drug-delivery

Study links paclitaxel devices to better survival in PAD, muddying debate

Released on January 9, 2020

Dive Brief: Peripheral arterial occlusive disease patients treated with a paclitaxel-coated device for chronic limb threatening ischaemia (CLTI) and intermittent claudication […]

Read more
Drug-delivery

Phillips-Medisize expands Denmark site

Released on January 8, 2020

Phillips-Medisize, a Molex company,  announced today that it has expanded its Global Innovation and Development site in Struer, Denmark. The Hudson, […]

Read more
Drug-delivery

Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Spirosure’s Fenom Pro™ Asthma Monitor in Multiple Countries

Released on January 8, 2020

CHICAGO and PLEASANTON, Calif., Jan. 8, 2020 /PRNewswire/ — Vyaire Medical, Inc. and Spirosure, Inc. have entered a five-year agreement for Vyaire to exclusively distribute Spirosure’s […]

Read more
Biotech Drug-delivery

Dyve Biosciences hires new chief scientific officer

Released on January 8, 2020

Transdermal drug therapy developer Dyve Biosciences announced that it appointed longtime Pfizer executive Chuck Harbert to the role of chief scientific officer. Harbert […]

Read more
Cardiology Drug-delivery

Medinol stent performs just as well as Medtronic Resolute, study says

Released on January 7, 2020

The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute Onyx stents from Medtronic (NYSE:MDT), according to new […]

Read more
Drug-delivery MedTech

Simplified devices, pharmacy access among 2020 catalysts for diabetes tech: analysts

Released on January 6, 2020

Dive Brief: Analysts at Baird Equity Research predict continued strong adoption of insulin pumps and continuous glucose monitoring systems in 2020, […]

Read more
Drug-delivery FDA Approved

Tandem Diabetes snags FDA approval for interoperable insulin pump software

Released on December 27, 2019

Faced with growing competition in the market for diabetes devices, Tandem Diabetes Care’s stock shot up in February when the U.S. […]

Read more
Drug-delivery FDA

FDA wants feedback on combination products guidance

Released on December 27, 2019

The FDA is seeking comment from sponsors of combination products on how they want the agency to respond to their scientific […]

Read more